Novel strategy for allergenicity risk assessment of proteins in regulated food and feed products
The aim of this call is to seek support for the development of a novel strategy for allergenicity risk assessment (RA) of proteins in food and feed. The current deadline is 30 Jun 2026, 14:30 UTC. The listed estimated value is €1,300,000.
What the buyer needs
- The aim of this call is to seek support for the development of a novel strategy for allergenicity risk assessment (RA) of proteins in food and feed.
- For both clinically-relevant cross-reactivity and de novo sensitisation, the project foresees the development of open source in silico prediction/appraisal tools to be validated with experimental data; assessment of…
- This novel strategy will enhance the reliability and speed of allergenicity RA and support process simplification and harmonisation, ultimately enabling better-informed risk management decision-making.
Procurement signals
- Procedure: EFSA/2026/OP/0010
- Procedure type: Source procedure code 47396220
- Contract type: Services contract (31095498)
- Submission method: Electronic submission
- Published: 17 Apr 2026
Procurement categories
CPV labels are not yet mapped locally, so the official category codes are shown as source-backed identifiers.
Programme and geography
Derived from official EU Funding & Tenders portal source fields. Use this as a shortlisting aid; the official tender record remains authoritative.
Source-backed details
Original identifiers and classification fields from the EU tender source.
- EFSA/2026/OP/0010
- 117980b2-c96a-48dc-af0f-9fcedb49d1b3-CN
- Source procedure code 47396220
- Services contract (31095498)
- 47352394
- Europe/Rome
- 30 Jun 2026, 14:30 UTC
- 1 Jul 2026, 09:20 UTC
Full official description
The aim of this call is to seek support for the development of a novel strategy for allergenicity risk assessment (RA) of proteins in food and feed. For both clinically-relevant cross-reactivity and de novo sensitisation, the project foresees the development of open source in silico prediction/appraisal tools to be validated with experimental data; assessment of future prospects for in silico tools; estimation of thresholds of allergological concern, and the development of a systematic tiered approach with a decision-making framework. This novel strategy will enhance the reliability and speed of allergenicity RA and support process simplification and harmonisation, ultimately enabling better-informed risk management decision-making.